NOS abnormal expression observed in the Fmr1-KO mouse brain leads to changes in the NO metabolism, protein nitration, and NF-κB activation that may be involved in the pathogenesis of intellectual disability in the FXS and may represent a new therapeutic target for this rare disorder. This evidence concerns the gene NOS2 and Intellectual disability.